Journal of Neuroscience, Vol 1, 585-595, Copyright © 1981 by Society for Neuroscience
Biosynthesis and release of beta-endorphin-, N-acetyl beta-endorphin-, beta-endorphin-(1-27)-, and N-acetyl beta-endorphin-(1-27)-like peptides by rat pituitary neurointermediate lobe: beta-endorphin is not further processed by anterior lobe
AS Liotta, H Yamaguchi and DT Krieger
Continuous labeling and pulse-chase techniques were employed to study the
synthesis and secretion of multiple forms of immunoreactive beta- endorphin
by cultured dispersed rat anterior lobe cells and intact neurointermediate
pituitary lobe. Cell and medium extract immunoreactive beta-endorphin
(specific immunoprecipitation and radioimmunoassay) exhibiting a Kav
similar to authentic beta-endorphin upon gel filtration was characterized
further by nonequilibrium isoelectric focusing, cation exchange
chromatography, reverse phase high pressure liquid chromatography, and
partial tryptic and chymotryptic mapping. Intact neurointermediate lobes
incorporated radiolabeled amino acids into four to six forms of
immunoreactive beta- endorphin. Four of these forms were physicochemically
similar to authentic beta-endorphin, N-acetylated beta-endorphin,
beta-endorphin- (1-27), and N-acetylated beta-endorphin-(1-27). Pulse-chase
studies indicated that a beta-lipotropin-like molecule served as a
metabolic intermediate for a beta-endorphin-like molecule. As
beta-endorphin-like material accumulated in the cell, some of it was
N-acetylated (approximately 18% at 2 hr chase and approximately 65% at 18
hr chase). At later chase times, beta-endorphin-(1-27)- and N-acetylated
beta- endorphin-(1-27)-like peptides were the predominant molecular species
detected. All endorphin forms were detected in unlabeled tissue maintained
in culture or tissue continuously labeled for 72 hr and were released into
the medium under basal, stimulatory (10(-8) M norepinephrine), or
inhibitory (10(-7) M dopamine) incubation conditions. In all cases,
beta-endorphin-(1-27)-like species were the predominant forms (more than
70% of total) present in the cells and released into the medium. In
contrast, approximately 90% of radiolabeled immunoreactive beta-endorphin
extracted from anterior lobe cells and medium similarly incubated appeared
to represent the authentic beta-endorphin molecule. Continuous labeling (72
hr) revealed the beta-lipotropin/beta-endorphin molar ratio to be
approximately 4. We conclude that, in anterior lobe, most of the
beta-endorphin is not processed further and is released intact, while in
neurointermediate lobe, it serves as a biosynthetic intermediate.